Items Tagged ‘anti-CD38’

December 15th, 2014

Daratumumab Anti-CD38 Monoclonal Antibody Appears Promising For the Treatment of Multiple Myeloma


An investigational new class of drugs, the anti-CD38 monoclonal antibodies, could be the next major advance in the treatment of multiple myeloma. These findings were presented at the 56th American Hematological Society Annual Meeting and Exposition, December 6–9, 2014, in San Francisco, California. Multiple myeloma is a cancer of plasma cells, which are a special […]

View full entry

Tags: anti-CD38, daratumumab, Multiple Myeloma, News, Recurrent Multiple Myeloma